Known origin
Manufacturer and manufacturing site must be identified beyond reseller branding.
The minimum evidence and governance conditions required before a material can be represented in the Notes for Innovation research catalogue.
Manufacturer and manufacturing site must be identified beyond reseller branding.
COA and analytical records should map to the exact original lot.
Intended use and jurisdiction must be reviewed before any supply pathway is activated.
Not merely a marketplace seller or private-label name.
Internal relabeling must not erase source traceability.
Generic marketing certificates do not satisfy the evidence model.
Manufacturer → exporter → intermediary → importer must be reconcilable.
No automatic assumption that “research only” resolves medicinal-product regulation.